Blog
RSS FeedPosted by Michael Wonder on 19 Mar 2018
Workshop on paediatric regulation – stakeholders to discuss how to boost development of medicines for children
19 March 2018 - Event to be broadcast live on 20 March. ...
Posted by Michael Wonder on 28 Feb 2018
Europe follows FDA with plans to help early Alzheimer's drugs
28 February 2018 - European regulators are following in the footsteps of the U.S. Food and Drug Administration with plans ...
Posted by Michael Wonder on 31 Jan 2018
How to better apply the paediatric legislation to boost development of medicines for children
31 January 2018 - EMA and European Commission invite stakeholders to register for joint workshop and support development of an ...
Posted by Michael Wonder on 23 Jan 2018
Competition in pharmaceuticals: more product- than price-oriented?
23 January 2018 - Competition is a subject always open to debate in health care, and pharmaceuticals are no exception, with ...
Posted by Michael Wonder on 23 Jan 2018
EMA surveys pharma companies on their preparedness for Brexit
23 January 2018 - Planning of regulatory steps needed to ensure medicines remain on EU market. ...
Posted by Michael Wonder on 17 Nov 2017
Towards a single development programme for new antibiotics in EU, Japan and US
17 November 2017 - EMA, PMDA and FDA to further align data requirements and explore options to streamline paediatric development. ...
Posted by Michael Wonder on 20 Oct 2017
New action plan to foster development of advanced therapies
20 October 2017 - Actions address specific challenges identified by stakeholders. ...
Posted by Michael Wonder on 09 Oct 2017
Is the NHS being held to ransom by big pharma?
7 October 2017 - Late last year Britain’s competition watchdog slapped a record £90m worth of fines on US drugs ...
Posted by Michael Wonder on 09 Aug 2017
Drug makers' hopes for gene therapy rise despite tiny sales in Europe
8 August 2017 - The science of gene therapy is finally delivering on its potential, and drug makers are now ...
Posted by Michael Wonder on 01 Aug 2017
EMA encourages tailored development of medicines for older people
1 August 2017 - EMA invites comments on reflection paper by 31 January 2018. ...
Posted by Michael Wonder on 29 Jul 2017
Concept paper on development and lifecycle of personalised medicines and companion diagnostic
28 July 2017 - Public consultation to end on 31 October 2017. ...
Posted by Michael Wonder on 29 Jul 2017
Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
26 July 2017 - Goldacre et al. set out to identify the policies of major pharmaceutical companies on transparency of trials, ...
Posted by Michael Wonder on 20 Jul 2017
EU watchdog concerned drug agency EMA may be too close to companies
19 July 2017 - The EMA, eager to accelerate access to promising new drugs, may be getting too cosy with ...
Posted by Michael Wonder on 06 Jul 2017
Brexit must not disrupt drug R&D, say pharma chiefs
6 July 2017 - Industry lobbying began shortly after British referendum last June. ...
Posted by Michael Wonder on 06 Jun 2017
Workshop: addressing unmet needs of children with pulmonary arterial hypertension
6 June 2017 - The EMA, the United States FDA and Health Canada are co-organising a workshop to discuss the ...